findmyKOL

Salman Arain, MD

Basic profile

Memorial Hermann

ORCIDNPI
RegionHouston, TX · South CentralSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Salman Arain is a Cardiology physician affiliated with Memorial Hermann. OpenAlex indexes 93 publications with 543 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
93publications

Distinct works indexed by OpenAlex, matched via ORCID.

543citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

10 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.4%
    Beta blocker17.4%
    Metoprolol Succinate59%Carvedilol35%Metoprolol Tartrate6%
    Part D<11 patients
    Statin15.7%
    Atorvastatin Calcium70%Rosuvastatin Calcium25%Pravastatin Sodium5%
    Part D<11 patients

    + 12 more classes in this area

  • Blood & clotting

    18.8%
    P2Y12 inhibitor13%
    Clopidogrel70%Brilinta18%Prasugrel Hcl12%
    Part D<11 patients
    Factor Xa inhibitor5.2%
    Eliquis77%Xarelto24%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.6%
    Proton pump inhibitor0.8%
    Pantoprazole Sodium100%
    Part D<11 patients
    H2 blocker0.7%
    Famotidine100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)74.9% facility · 25.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”